Jingmei Xiao

496 total citations
23 papers, 294 citations indexed

About

Jingmei Xiao is a scholar working on Psychiatry and Mental health, Physiology and Molecular Biology. According to data from OpenAlex, Jingmei Xiao has authored 23 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 7 papers in Physiology and 6 papers in Molecular Biology. Recurrent topics in Jingmei Xiao's work include Schizophrenia research and treatment (11 papers), Diet and metabolism studies (7 papers) and Tryptophan and brain disorders (5 papers). Jingmei Xiao is often cited by papers focused on Schizophrenia research and treatment (11 papers), Diet and metabolism studies (7 papers) and Tryptophan and brain disorders (5 papers). Jingmei Xiao collaborates with scholars based in China, United States and United Kingdom. Jingmei Xiao's co-authors include Renrong Wu, Yujun Long, Jingping Zhao, Ye Yang, Chenchen Liu, Ye Yang, Gangrui Hei, Fangkun Liu, Shan‐Tung Tu and Jing Huang and has published in prestigious journals such as Scientific Reports, Biological Psychiatry and Schizophrenia Bulletin.

In The Last Decade

Jingmei Xiao

20 papers receiving 290 citations

Peers

Countries citing papers authored by Jingmei Xiao

Since Specialization

Citations

This map shows the geographic impact of Jingmei Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingmei Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingmei Xiao more than expected).

Fields of papers citing papers by Jingmei Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingmei Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingmei Xiao. The network helps show where Jingmei Xiao may publish in the future.

Co-authorship network of co-authors of Jingmei Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingmei Xiao. A scholar is included among the top collaborators of Jingmei Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingmei Xiao. Jingmei Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metformin-improved cognitive impairment in patients with schizophrenia is correlated with activation of tricarboxylic acid cycle and restored functional connectivity of hippocampus 2025 ·BMC Medicine ·(unknown), Jingmei Xiao, Yujun Long, Ting Cao, (unknown), Gangrui Hei, (unknown), (unknown), Jing Huang, (unknown), Hualin Cai, Renrong Wu	0
2	Efficacy and Safety of Sulforaphane Added to Antipsychotics for the Treatment of Negative Symptoms of Schizophrenia 2025 ·The Journal of Clinical Psychiatry ·Jing Huang, (unknown), Hua Jin, Fangkun Liu, Gangrui Hei, Ziwei Teng, Jingmei Xiao, (unknown), (unknown), John M. Davis, Ping Shao, Robert C. Smith	3
3	A comprehensive metabolomic and lipidomic study of olanzapine in the treatment of first-episode schizophrenia 2025 ·Asian Journal of Psychiatry ·(unknown), Yujun Long, Jingmei Xiao, Ying Wang, Xiaoyi Wang, Ping Shao, Manli Huang, Yifeng Xu, Fang Liu, Yanqing Tang, Xijia Xu, Xiaoli Wu, Yingjun Zheng, (unknown), Jin Yang, Jing Huang, Rongling Wu	1
4	Effects of Accelerated Intermittent Theta Burst Stimulation Targeting the Superior Frontal Gyrus on Cognitive Function in Patients With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial 2025 ·Biological Psychiatry ·(unknown), (unknown), Yu‐Han Su, (unknown), Yuyan Huang, Jingmei Xiao, (unknown), (unknown), Ping Shao, Renrong Wu	0
5	Exploring the latent cognitive structure in schizophrenia: implications for antipsychotic treatment responses 2024 ·European Archives of Psychiatry and Clinical Neuroscience ·(unknown), (unknown), Gangrui Hei, Yujun Long, Jingmei Xiao, (unknown), Li Li, (unknown), Xiaoyi Wang, (unknown), Yuyan Huang, (unknown), Jing Huang, (unknown), Ying Wang, Jingping Zhao, (unknown), Renrong Wu	0
6	The effects of probiotics plus dietary fiber on antipsychotic-induced weight gain: a randomized clinical trial 2022 ·Translational Psychiatry ·Jing Huang, Chenchen Liu, Ye Yang, (unknown), Jingmei Xiao, Yujun Long, Bing Lang, (unknown), (unknown), Xiaoyi Wang, Fangkun Liu, Jingping Zhao, (unknown), Ti‐Fei Yuan, Renrong Wu	23
7	Previous exposure to antipsychotic drug treatment is an effective predictor of metabolic disturbances experienced with current antipsychotic drug treatments 2022 ·BMC Psychiatry ·Ye Yang, Peng Xie, Yujun Long, Jing Huang, Jingmei Xiao, Jingping Zhao, (unknown), Renrong Wu	3
8	Altered regional homogeneity and cognitive impairments in first-episode schizophrenia: A resting-state fMRI study 2022 ·Asian Journal of Psychiatry ·Yuyan Huang, (unknown), Gangrui Hei, Ye Yang, Yujun Long, Xiaoyi Wang, Jingmei Xiao, Xijia Xu, Xueqin Song, (unknown), (unknown), Jing Huang, Ying Wang, Jingping Zhao, Renrong Wu	24
9	Internet addiction among teenagers in a Chinese population: Prevalence, risk factors, and its relationship with obsessive-compulsive symptoms 2022 ·Journal of Psychiatric Research ·(unknown), Ziwei Teng, (unknown), (unknown), Jingmei Xiao, (unknown), (unknown), Yi Yang, Yan Hu, Jindong Chen, Renrong Wu, Jingping Zhao, (unknown), (unknown)	21
10	PCSK9 mediates dyslipidemia induced by olanzapine treatment in schizophrenia patients 2022 ·Psychopharmacology ·Jing Huang, Jingmei Xiao, (unknown), Ping Shao, Mengxi Sun, Yujun Long, Xiaoyi Wang, (unknown), (unknown), Ye Yang, (unknown), (unknown), Peng Xie, (unknown), Jingping Zhao, Renrong Wu	7
11	Identifying and revealing different brain neural activities of cognitive subtypes in early course schizophrenia 2022 ·Frontiers in Molecular Neuroscience ·(unknown), (unknown), Gangrui Hei, Ye Yang, Yujun Long, Xiaoyi Wang, Jingmei Xiao, Yuyan Huang, Xueqin Song, Xijia Xu, (unknown), Jing Huang, Ying Wang, Jingping Zhao, Renrong Wu	6
12	Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine 2022 ·Frontiers in Pharmacology ·(unknown), (unknown), Jingmei Xiao, Yi‐Qi Zhang, Rong Li, Yang Yang, Li Shen, Fei Luo, Wen Dai, (unknown), (unknown), (unknown), (unknown)	6
13	Dietary fiber and probiotics for the treatment of atypical antipsychotic-induced metabolic side effects: study protocol for a randomized, double-blind, placebo-controlled trial 2021 ·Trials ·Chenchen Liu, (unknown), Jingmei Xiao, Yuyan Huang, (unknown), (unknown), Peng Xie, Ye Yang, Jingping Zhao, Renrong Wu	10
14	The Association Between Metabolic Disturbance and Cognitive Impairments in Early-Stage Schizophrenia 2021 ·Frontiers in Human Neuroscience ·(unknown), Gangrui Hei, Ranran Li, Ye Yang, Chenchen Liu, Jingmei Xiao, Yujun Long, Ping Shao, Jing Huang, Jingping Zhao, Renrong Wu	9
15	The Association Between Cognitive Deficits and Clinical Characteristic in First-Episode Drug Naïve Patients With Schizophrenia 2021 ·Frontiers in Psychiatry ·(unknown), Gangrui Hei, Ye Yang, Chenchen Liu, Jingmei Xiao, Yujun Long, Jing Huang, Jingping Zhao, Renrong Wu	8
16	Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis 2021 ·Psychopharmacology ·Ye Yang, Yujun Long, (unknown), Chenchen Liu, Jingmei Xiao, Renrong Wu, Jingping Zhao	23
17	Optimizing and Individualizing the Pharmacological Treatment of First-Episode Schizophrenic Patients: Study Protocol for a Multicenter Clinical Trial 2021 ·Frontiers in Psychiatry ·Jingmei Xiao, Jing Huang, Yujun Long, Xiaoyi Wang, Ying Wang, Ye Yang, Gangrui Hei, Mengxi Sun, Jin Zhao, Li Li, (unknown), (unknown), (unknown), Chenchen Liu, Peng Xie, Yuyan Huang, Renrong Wu, (unknown), (unknown)	11
18	Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients 2020 ·Frontiers in Pharmacology ·Jing Huang, Gangrui Hei, Ye Yang, Chenchen Liu, Jingmei Xiao, Yujun Long, (unknown), (unknown), Jingping Zhao, Renrong Wu	27
19	Effects of olanzapine treatment on lipid profiles in patients with schizophrenia: a systematic review and meta-analysis 2020 ·Scientific Reports ·(unknown), Yiqi Zhang, (unknown), Chen Ding, Wenjie Dai, Xin Su, Wen Dai, Jingmei Xiao, Zhenhua Xing, (unknown)	24
20	Public behavior change, perceptions, depression, and anxiety in relation to the COVID-19 outbreak 2020 ·Open Forum Infectious Diseases ·Jing Huang, Fangkun Liu, Ziwei Teng, Jindong Chen, Jingping Zhao, Xiaoping Wang, Ying Wu, Jingmei Xiao, Ying Wang, Renrong Wu	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact